Recently, Konstantinos Apostolou, R&D senior manager at our Athens Development facility, was featured in European Pharmaceutical Manufacturer, where he explored the rapid rise of highly potent active pharmaceutical ingredients (HPAPIs). The market is valued at $185.5 billion in 2024 and […]
Annex 1 to EU GMP for sterile products came into effect in 2023, and while technically it is for the EU, in practice it has rapidly become a worldwide standard. It has brought in a number of additional formal requirements […]
In the ever-evolving pharmaceutical landscape, non-sterile liquid solutions have emerged as one of the most adaptable and efficient dosage forms available today. Unlike sterile preparations, these formulations do not require aseptic manufacturing conditions, yet they must maintain an exceptionally high […]
At Adragos Jura, ensuring pharmaceutical quality is central to our mission of delivering medicines that are safe, effective, and consistently reliable. Even minor lapses could impact product quality and efficacy, which is why authorities such as Swissmedic, FDA, and EMA […]
In modern healthcare, innovation in drug delivery systems is reshaping how treatments reach the patient. Among the most impactful of these advancements is the prefilled syringe, a ready-to-use delivery system designed to simplify drug administration, improve patient safety, and enhance […]
When choosing a partner to support your pharmaceutical manufacturing, quality control is a crucial factor that can define the safety, effectiveness, and marketability of your product. This makes quality control important for ensuring safety, compliance, and operational efficiency throughout the […]
Get notified on our latest news.
